Primary Distribution Activities

Similar documents
Materials Management Traceability, CEPs and managing non-conforming sites

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Inspection of API Manufacturers & Update on Registration Process

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs

Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Dealing with Quality Defects and Rapid Alerts. David Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

Guide to Good Distribution Practice of Medicinal Products for Human Use

MA Compliance Reviews Implications for Manufacturers

An analysis of quality product defects in the centralised procedure

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

Supervision of manufacturers: What is expected of National Competent Authorities?

Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties.

Product Quality Review: Overview and Feedback from Inspection

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Guidance on preparing for Brexit in the centralised procedure

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Falsified Medicines Directive: Irish Medicines Verification Organisation (IMVO) update for HPRA GMP Conference LEONIE CLARKE - 7 TH FEBRUARY 2017

GIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers

Brexit Guidance for Stakeholders Human and veterinary medicines

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices

Self-Inspection and its potential benefits via ICH Q9 & Q10

Case Study: how reports of falsified medicinal products can impact wholesale distributors

Earlsfort Centre Earlsfort Terrace Dublin 2 Ireland

Deficiencies found in Inspections and QP Responsibilities

Regulatory Update. Paul Sexton. QP Forum

Regulatory Update. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

Guide for Recall of Medicinal Products for Human and Veterinary Use

Good Clinical Practice Inspections Expectations for Compliance with Sponsor Responsibilities, Part II

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013

COMPILATION OF COMMUNITY PROCEDURES ON INSPECTIONS AND EXCHANGE OF INFORMATION

STANDARD OPERATING PROCEDURE TEAM INSPECTIONS

GS1 Ireland Healthcare User Group (HUG) Information Day

Guide to Scientific and Regulatory Advice for GXP activities

The interface between Good Clinical Practice and Good Manufacturing Practice

Guide to Quality Defect Investigation Reports

Quality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1

European Medicines Agency Inspections

Journal of Chemical and Pharmaceutical Research

Qualified Persons (IMP) Don Wallace Regional QA Pharmacist 27 th May 2014

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

Guide to the in-vitro diagnostic medical devices legislation

Session 4: Quality Defect Investigations and Product Recalls

Quality Assessment & GMP Similarities & Differences

Compliance with the GMP Standard in the International Level

OFFICIAL CONTROL AUTHORITY BATCH RELEASE (OCABR) OF VACCINES AND BLOOD PRODUCTS

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

National laws. National Competent Authority / Authorities. Orders, ordinances (supervision)

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager

Safety Features Required by the Falsified Medicines Directive 2011/62/EU

QP s experience with QRM. Fergus O Connell QA Manager AMS Laboratories

Data Collection Tools Functions, Indicators & Sub-Indicators

Verification processes in the supply chain. Workshop for MAHs, Helsinki, 18 Sep 2018 Teijo Yrjönen, FiMVO

Qualified Persons in the Pharmaceutical Industry Study Guide

Role of Official Medicines Control Laboratories (OMCL) in assessing quality of biologicals.

Guide to Quality System for General Sale Wholesale Distributors

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS FOR VACCINE ANTIGEN MASTER FILE (VAMF) CERTIFICATION

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Submission of comments on Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use (SANCO/C8/AM/an D(2010) )

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

COMMISSION RECOMMENDATION. of XXX. on the audits and assessments performed by notified bodies in the field of medical devices

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

TUV SUD BABT PRODUCTION QUALITY CERTIFICATION SCHEME

Guide to Parallel Imports of Human Medicines

Healthcare Good Distribution Practice (GDP)

Medical Device Regulatory Framework

Guide to Fees for Veterinary Products

EMA role in GMP Manufacturing and Quality Compliance

Guide for Distributors of Medical Devices

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Manufacturers serialisation challenges with FMD & DR implementation

CO-ORDINATION OF NOTIFIED BODIES PPE Regulation 2016/425 RECOMMENDATION FOR USE

FIMVO END USER AND ISV WORKSHOP. Paul Mills - EMVO

The APIC Audit Programme Version 5, July 2017

GxP Inspections within the Centralised Procedure. Brendan Cuddy Inspections Sector

Control of veterinary products and vaccines Inspection system, monitoring plan, monitoring of vaccines distribution

Marie-Claire Good, RG and GCP Manager James Rickard, Deputy Chief Pharmacist Technical Services Cheryl Lawrence, Senior Research Pharmacist

Qualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008

Members must be a manufacturer, wholesaler or distributor of complementary medicine, dietary food supplements, health foods or beverages.

REVISED COMPILATION OF COMMUNITY PROCEDURES ON ADMINISTRATIVE COLLABORATION AND HARMONISATION OF INSPECTIONS

PROCEDURE FOR BATCH RELEASE OF VACCINES ONTO THE MARKET User's manual

MINISTRY OF HEALTH ORDINANCE

Manufacturers of In-Vitro Diagnostic

Overview of HPRA Sampling and Analysis (S&A) Programme

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

Guide to field safety corrective actions for medical devices and in-vitro diagnostic medical devices

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

Transcription:

Primary Distribution Activities Wholesale Distribution Information Day, Paul Sexton GMP Manager Date Insert on Master Slide Slide 1

Topics What is a Primary Distributor / Wholesaler Special Responsibilities of the Primary Distributor Typical Deficiencies Slide 2

What is a Primary Distributor? (1) Not specifically defined in legislation Wholesaler who first places the batch of product on the Irish market on behalf of the MAH Not mandatory for MAH to appoint a primary wholesaler Where a Primary Distributor is appointed by the MAH it may be named on product packaging (not mandatory) Slide 3

What is a Primary Distributor? (2) Primary Distributor may distribute to the retailers or other wholesalers Special cases sourcing PA/PL product from UK other than as Primary Distributor appointed by MAH Dual Product Registration scheme applies. Parallel importation (PPA required & Manufacturer s Authorisation (MIA)) MIA required for importation from outside EEA Slide 4

What is a Primary Distributor? (3) IMB s identification of Primary Distributor Wholesaler s Authorisation - Application should state intention to act as Primary Distributor - List on Annex to the Authorisation - Name of MAH and first 4 nos. of PA (PA0001) or EU numbers (EU/1/00/000) for Centrally Authorised Product Slide 5

Responsibilities of Primary Distributor (1) Ensuring that batches are certified by the QP before distribution? (a) Primary Distributor storing product under quarantine not yet released by the QP. (contract storage for manufacturer) Documented and agreed mechanism (TA) between the manufacturer and Primary Wholesaler. Slide 6

Responsibilities of Primary Distributor (2) Ensuring that batches are certified by the QP before distribution (b) Product QP released but entering EEA country. Ireland from another Control Report (ref Manufacturing Regulations, SI 539) - document provided by manufacturer or distributor supplying the product to the Primary Distributor in Ireland. Slide 7

Responsibilities of Primary Distributor (3) Should document: Product manufactured in accordance with:- - product authorisation - GMP Signed by QP Date Insert on Master Slide Slide 8

Responsibilities of Primary Distributor (4) Official Control Authority Batch Release Additional testing performed at Official Medicines Control Laboratory (OMCL) Applies to certain biological medicines (e.g. Vaccines, blood products) IMB notifies MAH s of products where OCABR is required for Irish market. Slide 9

Responsibilities of Primary Distributor (5) Official Control Authority Batch Release Primary Distributor to verify that OCABR certificate has been issued by OMCL successful testing prior to distribution of product. Technical Agreement with MAH to cover products requiring OCABR. Slide 10

Responsibilities of Primary Distributor (6) Product Recall MAH often assigns particular responsibilities to Primary Distributor for recall of medicines. E.g co-ordination of recall and reconciliation of recalled product Responsibilities assigned to be covered in a Technical Agreement with MAH. Recall procedure should reflect responsibilities Slide 11

Responsibilities of Primary Distributor (7) Medical Samples Primary Distributor may be responsible for distribution of Free Samples to Medical Representatives Traceability of samples to be maintained. Slide 12

Responsibilities of Primary Distributor (8) Complaints Primary Distributor may receive complaints relating to product quality. Technical Agreement should cover communication of complaints to MAH. Slide 13

Typical Deficiencies (1) Responsibilities of Primary Distributor not adequately defined in Technical Agreements or Procedures (SOPs for Recall / Complaints) Actual supply chain not verified for goods received Complexity of operation not reflected in QMS (e.g. different requirements for different MAHs with regard to cold chain supply) Inadequate training with regard to primary distribution responsibilities Slide 14

Typical Deficiencies (2) Products released to saleable stock without verification of OCABR certification Products released to saleable stock without verifying batch certification for Irish market Date Insert on Master Slide Slide 15

Thank you Slide 16